Evaluation of Extended Medication Labels by Health Professionals
Article Sidebar
Main Article Content
Abstract
objective: To evaluate the appropriateness of extended medication labels for outpatients by health professionals. Method: The study surveyed the opinions among 57 health professionals in Tron hospital using questionnaires on the practicality and content of according to a convenient of 18 extended medication labels for outpatients. The study also surveyed the opinions among 43 conveniently sampled pharmacists including those working in hospitals and Uttaradit Public Health Office, those in the training program of the College of Pharmaceutical and Health Consumer Protection of Thailand, and alumni of Faculty of Pharmaceutical Sciences at Chiang Mai University. Moreover, 2 experts (one physician and one pharmacist) critically appraised the extended medication labels. Results: Health professionals in Tron hospital and selected subjects showed high levels of agreement on the use of extended medication labels in patients with the opinion scores of 3.86±0.87 and 3.51±1.01, respectively (out of the full score of 5). However, both groups of subjects (52.63 and 53.49%, respectively) felt that the content in extended medication labels needed revision. Expert who was physician recommended the revision of all extended medication labels, while expert who was pharmacist recommended the revision of 10 of extended medication labels. Conclusion: Health professionals agreed with the use of extended medication labels in outpatients, but their content should be revised to be concise and understandable. The result of this study could be input for developing extended medication labels in the “Rational Drug Use Hospital” project
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Bagnall BG. Pharmaceutical prescribing and labeling information online: The challenge of national regulations and the global internet [online].1997 [cited Jan 4, 2016]. Available from: www.isoc.org/inet98/proceedings/8x/8x_3.htm.
3. World Health Organization. Promoting rational use of medicines: core components [online]. 2002 [cited Jan 4, 2016]. Available from: apps.who.int/ medicine docs/pdf/h3011e/h3011e.pdf.
4. U.S. Food and Drug Administration. Providing effective information to consumers about pres- cription drug risks and benefits [online]. 2009 [cited Dec15, 2015]. Available from: www.fda.gov/ downloads/Drugs/NewsEvents/UCM182799.pdf.
5. Food and Drug Administration. Guideline for leaflet development [online]. 2013 [cited Dec 9, 2015]. Available from: drug.fda.moph.go.th/zone_law/files/ d6.pdf.
6. National Committee on Drug System Development. National drug policy B.E. 2554 and strategies for drug system development B.E. 2555-2559. Nonta- buri: Publising House of Agricultural Cooperative Federation of Thailand; 2011.
7. Subcommittee on the Promotion of Rational Drug Use. Rational drug use hospital project (updated on Sep 2014) [online]. 2014 [cited Feb 8, 2016]. Available from: drug.fda.moph.go.th:81/nlem.in.th/
sites/default/files/attachments/1rdu_hospital_projectedit_oct14_edit.pdf.
8. Shayakul C, Chongtrakul P, Wananukul W, Punnupoorot P, Kanjanarat P, Yotsombut K , et al. Mannual of rational drug use hospital. Nontaburi: Publising House of the Agricultural Cooperative Federation of Thailand; 2015.
9. Chongtrakul P, Chunprasert S, Indradat S, Tunksiriwonkan J. Suggestions to improve labeling and extended labels to promote rational drug use. Bangkok: Wanida printing; 2015.
